177Lu-anti-PD-L1 SdAb in Metastatic Solid Tumors
NCT 06305962 Brief Summary This is a first-in-human, open-label study consisting of…
Read more arrow_forwardNCT 06305962 Brief Summary This is a first-in-human, open-label study consisting of…
Read more arrow_forwardNCT 05086692 Brief Summary This is a Phase 1/2, multi-center, open-label, dose-escalation…
Read more arrow_forwardNCT 05923008 Brief Summary This is a phase 1/2 multicenter, open-label, first-in-human…
Read more arrow_forwardNCT 05858164 Brief Summary Researchers are looking for a better way…
Read more arrow_forwardNCT 05984277 Brief Summary The purpose of eVOLVE-Lung02 is to test…
Read more arrow_forwardNCT 05221840 Brief Summary This is a Phase III, randomised, double-blind,…
Read more arrow_forwardNCT 04801095 Brief Summary This study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics,…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 05920356 Brief Summary The primary objective of this study is…
Read more arrow_forwardNCT 05789082 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forward